1 – 14 of 14
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment Preferences for Acute Allergic Reactions : A Discrete Choice Experiment
(
- Contribution to journal › Article
-
Mark
Disease burden and unmet need for acute allergic reactions – A patient perspective
(
- Contribution to journal › Article
- 2020
-
Mark
The value of reducing health risks based on willingness to pay in Sweden
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Dread and Risk Elimination Premium for the Value of a Statistical Life
(
- Contribution to journal › Article
- 2016
-
Mark
Preferences for improvements in attributes associated with basal insulin : a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden
(
- Contribution to journal › Article
-
Mark
Dread and Risk Elimination Premium for the Value of a Statistical Life
2016) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Measuring the End of Life Premium in Cancer using Individual ex ante Willingness to Pay
2016) In Working Papers(
- Working paper/Preprint › Working paper
-
Mark
Value of a QALY and VSI Estimated with the Chained Approach
(
- Working paper/Preprint › Working paper
-
Mark
Chained Approach vs Contingent Valuation for Estimating the Value of Risk Reduction
(
- Working paper/Preprint › Working paper
-
Mark
Betalningsviljan för att minska risken för icke-dödliga och dödliga skador i samband med vägtrafikolyckor – en pilotstudie med jämförelse av CV och kedje-ansats
2016) In IHE Rapport(
- Book/Report › Report
-
Mark
Betalningsviljan för att minska risken för icke-dödliga och dödliga skador i samband med vägtrafikolyckor – en studie med kedje-ansats
2016) In IHE Rapport(
- Book/Report › Report
-
Mark
Societal cost of subcutaneous and intravenous trastuzumab for HER2-positive breast cancer – An observational study prospectively recording resource utilization in a Swedish healthcare setting
(
- Contribution to journal › Article
- 2014
-
Mark
Willingness to pay for a new drug delivery in Parkinson patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Effect of Treatment with Natalizumab on Ability to Work in People with Multiple Sclerosis Productivity Gain Based on Direct Measurement of Work Capacity before and after 1 Year of Treatment
(
- Contribution to journal › Article